Yamo Pharmaceuticals

0 followers

‌

Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.

Industries

Biotechnology, Pharmaceutical

Headquarters

New York, United States

Employees

1-10

Links

Org chart

Chuck Bramlage

Chief Executive Officer

Chuck Bramlage

Collapse

Eugene Prahin

Chief Financial Officer

Tracy Fischer

Senior Vice President – Regulatory Affairs & Quality

Uyen Nguyen

Vice President Of Clinical Research Operations

Brian Cahill

Chief Financial Officer

Teams

This company has no teams yet

Similar companies

Bristol-Myers Squibb

175 followers

Genentech

150 followers

Abbott

278 followers

Cytel

5 followers

Legend Biotech

5 followers

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Immunome

2 followers

Roche

238 followers

Dragonfly Therapeutics

1 follower

Invivyd

1 follower

Explore companies